You Are Here    News

News
Vaccination could have important role in control of UK HCV epidemic among people who inject drugs
by Michael Carter, 2016-06-30 08:00
A vaccine, even with low efficacy, could lead to meaningful reductions in the incidence and prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID), a modelling study published in PLoS One shows.   An international team of investigators analysed the potential impact of three different vaccination scenarios – low, moderate and high efficacy -

PRO-140 antibody injections maintain viral suppression in phase 2 study
by Liz Highleyman, 2016-06-28 08:30
Subcutaneous injections of PRO 140, a monoclonal antibody that blocks HIV entry into cells, was well-tolerated and maintained undetectable viral load for more than a year after stopping antiretroviral therapy (ART) in patients with viral suppression, according to a study presented at the ASM Microbe 2016 meeting last week in Boston. HIV uses two co-receptors

US National HIV Testing Day boosts numbers testing
by Roger Pebody, 2016-06-27 16:40
Today, June 27, is National HIV Testing Day in the United States and a study just published in Morbidity and Mortality Weekly Report shows that in previous years, this event has resulted in a statistically significant increase in the number of people diagnosed with HIV.National HIV Testing Day has been observed since 1995 and

ART use averting huge numbers of opportunistic infections amomg HIV-positive children in lower-income countries
by Michael Carter, 2016-06-27 08:40
There has been a decrease in cases of many opportunistic infections (OIs) among HIV-positive children in low- and middle-income countries thanks to antiretroviral therapy (ART), a meta-analysis published the June 15th edition of Clinical Infectious Diseases shows. Investigators estimated that use of ART is averting over 161,000 opportunistic infections each year, saving $17 million per

ART use averting huge numbers of opportunistic infections among HIV-positive children in lower-income countries
by Michael Carter, 2016-06-27 08:40
There has been a decrease in cases of many opportunistic infections (OIs) among HIV-positive children in low- and middle-income countries thanks to antiretroviral therapy (ART), a meta-analysis published the June 15th edition of Clinical Infectious Diseases shows. Investigators estimated that use of ART is averting over 161,000 opportunistic infections each year, saving $17 million per

ART use averting huge numbers of opportunistic infections among children living with HIV in lower-income countries
by Michael Carter, 2016-06-27 08:40
There has been a decrease in cases of many opportunistic infections (OIs) among children living with HIV in low- and middle-income countries thanks to antiretroviral therapy (ART), a meta-analysis published in the June 15th edition of Clinical Infectious Diseases shows. Investigators estimated that use of ART is averting over 161,000 opportunistic infections each year,

PrEP use is rising fast in US, but large racial disparities remain
by Liz Highleyman, 2016-06-24 11:00
More than 49,000 people in the US have filled prescriptions for Truvada for pre-exposure prophylaxis at retail pharmacies, according to the results of a survey by Gilead Sciences presented this week at the ASM Microbe conference in Boston. Among PrEP users with available data, most were white gay men; black people used PrEP much less